Analysis | Metabolite Name | Measured Value | Units | CASE_CONTROL | Chemotherapy | Drug | Race | TIMEPOINT | Tamoxyfen | Taxane |
---|---|---|---|---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 2928 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 3080 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 3851 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 4242 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 4375 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 4668 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 4741 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 4765 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 4821 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 5027 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 5507 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 5673 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 5849 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 6101 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 6178 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 6240 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 6292 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 6530 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 6596 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 6646 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 6700 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 6707 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 6982 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 7080 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 7127 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 7214 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 7383 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 7550 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 7592 | Peak area | Control | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 7625 | Peak area | Case | N | Exemestane | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 7688 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 7842 | Peak area | Control | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 7863 | Peak area | Control | Y | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 7908 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 7940 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 7945 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 7976 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 7991 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 8132 | Peak area | Case | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 8295 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 8295 | Peak area | Case | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 8411 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 8685 | Peak area | Case | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 8713 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 8738 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 8848 | Peak area | Control | Y | Exemestane | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 9009 | Peak area | Control | Y | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 9153 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 9321 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 9515 | Peak area | Control | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 9533 | Peak area | Control | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 9599 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 9604 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 9648 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 9652 | Peak area | Control | Y | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 9785 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 9789 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 9804 | Peak area | Control | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 9843 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 9996 | Peak area | Control | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 10054 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 10275 | Peak area | Case | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 10312 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 10443 | Peak area | Case | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 10468 | Peak area | Control | N | Exemestane | Black | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 10515 | Peak area | Case | Y | Exemestane | Black | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 10586 | Peak area | Control | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 10697 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 10982 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 10985 | Peak area | Case | Y | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 11050 | Peak area | Case | N | Exemestane | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 11218 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 11390 | Peak area | Control | Y | Exemestane | White | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 11434 | Peak area | Control | Y | Letrozole | White | Baseline | Y | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 11493 | Peak area | Control | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 11606 | Peak area | Control | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 11621 | Peak area | Control | Y | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 11835 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 12028 | Peak area | Control | N | Exemestane | Black | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 12108 | Peak area | Case | N | Exemestane | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 12112 | Peak area | Control | N | Letrozole | Black | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 12194 | Peak area | Case | N | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 12218 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 12661 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 13499 | Peak area | Case | N | Letrozole | White | Baseline | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 14432 | Peak area | Control | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 14802 | Peak area | Case | N | Letrozole | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 14861 | Peak area | Case | N | Exemestane | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 14908 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 15084 | Peak area | Case | Y | Exemestane | Black | 3 Month | N | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 15084 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 15102 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 15282 | Peak area | Case | N | Exemestane | White | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 16068 | Peak area | Case | Y | Letrozole | White | 3 Month | Y | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 16096 | Peak area | Case | N | Letrozole | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 17414 | Peak area | Case | N | Letrozole | Black | 3 Month | N | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 19918 | Peak area | Case | Y | Exemestane | White | Baseline | N | Y |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 20544 | Peak area | Control | N | Letrozole | White | 3 Month | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 22689 | Peak area | Case | Y | Exemestane | White | Baseline | Y | N |
Reversed phase NEGATIVE ION MODE | HEXACOSANOIC ACID (CAS# 506-46-7); (M-H)- | 46311 | Peak area | Control | N | Exemestane | White | 3 Month | N | N |